BIOMAT Database Logo BIOMAT Database Logo

Peripheral lymphocyte DNA damage and oxidative status after eradication therapy in patients infected with Helicobacter pylori. 2011

Ahmet C Dulger, and Mehmet Aslan, and Yaşar Nazligul, and Mehmet Horoz, and Cengiz Bolukbas, and Fusun F Bolukbas, and Hakim Celik, and Abdurrahim Kocyigit
Yuzuncu Yil University, Medicine Faculty, Department of Gastroenterology, Van, Turkey.

BACKGROUND Helicobacter pylori infection has been shown to cause inflammation, increased production of reactive oxygen species, and oxidative DNA damage in the gastric mucosa. However, the effect of eradication treatment on DNA damage in patients infected with H. pylori is unclear. OBJECTIVE The objective of this study was to investigate the effect of eradication treatment on peripheral DNA damage and oxidative status in patients wth H. pylori infection. METHODS The study involved 42 patients positive for H. pylori (Hp+) and 25 patients negative for H. pylori (Hp-). Peripheral lymphocyte DNA damage was assessed using the alkaline comet assay and plasma oxidative status was determined. Measurements were conducted at baseline and 2 weeks after eradication treatment. RESULTS The total antioxidant status (TAS) was lower in Hp+ patients than in Hp- patients (P <0.05), while the total oxidant status (TOS), oxidative stress index (OSI), and peripheral lymphocyte DNA damage were higher (P <0.001 for all parameters). TOS, OSI, and peripheral lymphocyte DNA damage were significantly lower after eradication treatment (P <0.001 for all parameters), while TAS was significantly higher (P <0.05). There was no correlation between TOS, OSI, peripheral lymphocyte DNA damage, and TAS and the histopathological degree of antral gastric inflammation in the Hp+ group (P >0.05). CONCLUSIONS Our results suggest that H. pylori eradication significantly decreases peripheral lymphocyte DNA damage and oxidative stress. Eradication treatment might help prevent the development of gastric cancer in patients with H. pylori infection.

UI MeSH Term Description Entries
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D004249 DNA Damage Injuries to DNA that introduce deviations from its normal, intact structure and which may, if left unrepaired, result in a MUTATION or a block of DNA REPLICATION. These deviations may be caused by physical or chemical agents and occur by natural or unnatural, introduced circumstances. They include the introduction of illegitimate bases during replication or by deamination or other modification of bases; the loss of a base from the DNA backbone leaving an abasic site; single-strand breaks; double strand breaks; and intrastrand (PYRIMIDINE DIMERS) or interstrand crosslinking. Damage can often be repaired (DNA REPAIR). If the damage is extensive, it can induce APOPTOSIS. DNA Injury,DNA Lesion,DNA Lesions,Genotoxic Stress,Stress, Genotoxic,Injury, DNA,DNA Injuries
D005260 Female Females
D005753 Gastric Mucosa Lining of the STOMACH, consisting of an inner EPITHELIUM, a middle LAMINA PROPRIA, and an outer MUSCULARIS MUCOSAE. The surface cells produce MUCUS that protects the stomach from attack by digestive acid and enzymes. When the epithelium invaginates into the LAMINA PROPRIA at various region of the stomach (CARDIA; GASTRIC FUNDUS; and PYLORUS), different tubular gastric glands are formed. These glands consist of cells that secrete mucus, enzymes, HYDROCHLORIC ACID, or hormones. Cardiac Glands,Gastric Glands,Pyloric Glands,Cardiac Gland,Gastric Gland,Gastric Mucosas,Gland, Cardiac,Gland, Gastric,Gland, Pyloric,Glands, Cardiac,Glands, Gastric,Glands, Pyloric,Mucosa, Gastric,Mucosas, Gastric,Pyloric Gland
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D000975 Antioxidants Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. Anti-Oxidant,Antioxidant,Antioxidant Activity,Endogenous Antioxidant,Endogenous Antioxidants,Anti-Oxidant Effect,Anti-Oxidant Effects,Anti-Oxidants,Antioxidant Effect,Antioxidant Effects,Activity, Antioxidant,Anti Oxidant,Anti Oxidant Effect,Anti Oxidant Effects,Anti Oxidants,Antioxidant, Endogenous,Antioxidants, Endogenous

Related Publications

Ahmet C Dulger, and Mehmet Aslan, and Yaşar Nazligul, and Mehmet Horoz, and Cengiz Bolukbas, and Fusun F Bolukbas, and Hakim Celik, and Abdurrahim Kocyigit
Oxidative DNA Damage Response in Helicobacter pylori-Infected Mongolian Gerbils.
September 2013, Journal of cancer prevention,
Ahmet C Dulger, and Mehmet Aslan, and Yaşar Nazligul, and Mehmet Horoz, and Cengiz Bolukbas, and Fusun F Bolukbas, and Hakim Celik, and Abdurrahim Kocyigit
DNA damage in patients infected by Helicobacter pylori.
April 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology,
Ahmet C Dulger, and Mehmet Aslan, and Yaşar Nazligul, and Mehmet Horoz, and Cengiz Bolukbas, and Fusun F Bolukbas, and Hakim Celik, and Abdurrahim Kocyigit
Increased oxidative DNA damage in Helicobacter pylori-infected human gastric mucosa.
March 1996, Cancer research,
Ahmet C Dulger, and Mehmet Aslan, and Yaşar Nazligul, and Mehmet Horoz, and Cengiz Bolukbas, and Fusun F Bolukbas, and Hakim Celik, and Abdurrahim Kocyigit
Peripheral blood lymphocyte population in children infected with Helicobacter pylori.
January 2003, Roczniki Akademii Medycznej w Bialymstoku (1995),
Ahmet C Dulger, and Mehmet Aslan, and Yaşar Nazligul, and Mehmet Horoz, and Cengiz Bolukbas, and Fusun F Bolukbas, and Hakim Celik, and Abdurrahim Kocyigit
Gene-specific oxidative DNA damage in Helicobacter pylori-infected human gastric mucosa.
June 2002, International journal of cancer,
Ahmet C Dulger, and Mehmet Aslan, and Yaşar Nazligul, and Mehmet Horoz, and Cengiz Bolukbas, and Fusun F Bolukbas, and Hakim Celik, and Abdurrahim Kocyigit
[Helicobacter pylori eradication therapy with omeprazole and amoxicillin: current status].
November 1994, Leber, Magen, Darm,
Ahmet C Dulger, and Mehmet Aslan, and Yaşar Nazligul, and Mehmet Horoz, and Cengiz Bolukbas, and Fusun F Bolukbas, and Hakim Celik, and Abdurrahim Kocyigit
[Eradication therapy for the remnant stomach infected with Helicobacter pylori ].
November 2005, Nihon rinsho. Japanese journal of clinical medicine,
Ahmet C Dulger, and Mehmet Aslan, and Yaşar Nazligul, and Mehmet Horoz, and Cengiz Bolukbas, and Fusun F Bolukbas, and Hakim Celik, and Abdurrahim Kocyigit
Possibility of chemoprevention by the eradication of Helicobacter pylori: oxidative DNA damage and apoptosis in H. pylori infection.
October 1997, The American journal of gastroenterology,
Ahmet C Dulger, and Mehmet Aslan, and Yaşar Nazligul, and Mehmet Horoz, and Cengiz Bolukbas, and Fusun F Bolukbas, and Hakim Celik, and Abdurrahim Kocyigit
[Gastrointestinal Diseases in the Era without Helicobacter pylori infection. Topics: II. Present Status of Helicobacter pylori Eradication Therapy and Problems after Eradication]
January 2017, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
Ahmet C Dulger, and Mehmet Aslan, and Yaşar Nazligul, and Mehmet Horoz, and Cengiz Bolukbas, and Fusun F Bolukbas, and Hakim Celik, and Abdurrahim Kocyigit
[Pseudomembranous colitis after Helicobacter pylori eradication therapy].
January 2006, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases,
Copied contents to your clipboard!